Actively Recruiting
Evaluating Optimal Treatment Lengths for Radiographic, Bacteriologically Unconfirmed Tuberculosis Found Through Active Case Finding
Led by University College, London · Updated on 2026-10-26
784
Participants Needed
4
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
The RADIO-TB trial is focused on people living in communities with high tuberculosis TB rates who have chest X-ray changes suggestive of TB but negative or unavailable sputum tests, called bacteriologically unconfirmed TB. These individuals often have few or no symptoms and face challenges in clinical management, including whether to start full TB treatment or be discharged without treatment. The trial aims to answer critical questions about the risks of delaying treatment, the shortest effective treatment duration, better diagnostic tests, and the cost-effectiveness and impact of different treatment strategies on TB transmission. Participants are randomly assigned to one of six groups. Five groups receive immediate TB treatment of varying lengths ranging from 8 to 24 weeks, involving combinations of isoniazid, rifampicin, pyrazinamide, and ethambutol. One group receives no initial treatment but is closely monitored for up to 78 weeks, with treatment started if TB progresses or is confirmed. The study uses computer-aided detection CAD software for screening and includes follow-up chest X-rays and microbiological testing. Throughout the 78-week follow-up period, participants attend at least 11 clinic visits for clinical evaluations, repeat imaging, sputum testing, and quality-of-life assessments. Baseline assessments include clinical exams, sputum culture, blood and respiratory sampling for novel diagnostics, and investigations for other conditions if needed. The primary outcome measures unfavorable TB outcomes such as the need to start treatment after initial visit due to progression or confirmation. Secondary measures include lung function, drug resistance, adverse events, and cost-effectiveness analysis. The trial is sponsored by University College London and conducted across several countries to inform TB treatment guidelines.
CONDITIONS
Brief Title
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
Research Team
H
Hanif Esmail, Prof
M
Mags Thomason, Dr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here